Accelerate your Translational Discovery efforts

Excelra's Biomarker Discovery Platform (BDPx) combines its proprietary database-GOBIOM, computational biology services and performs data analytics on top of all; in order to provide the optimal solutions to our collaborators.

Right Biomarker for Right Trial/ Accelerate Translational Discovery

In the era of pharmacogenomics and personalized medicine, a lot of data needs to be gathered, analyzed and predicted in order to have a differentiated strategy with a wealth of information present in what is not known yet. Excelra's strengths in big data and predictive analytics allows researchers to go further from the reported biomarkers in the literature with priority on clinical significance.

Features

  • 80,000+ Biomarkers (type, phase, therapeutic area etc.)
  • Disease agnostic
  • Custom pipelines to analyze data from various OMICS approaches
  • Data integration and processing to create custom solutions
  • Predict MOA and involvement of variants in disease pathophysiology

Tailor-made Biomarkers

To explore our services, write to us at info@excelra.com

Scroll To Top